CAPLIN POINT LABORATORIES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,311 INR | +0.94% |
|
-2.92% | -3.33% |
| 08:19am | Caplin Point Laboratories Gets Colombian Drug Regulator's Approval for Soft Gel Capsules Unit in India | MT |
| Apr. 16 | Caplin Point Arm Gets US FDA Final Nod for Ofloxacin Ophthalmic Solution | MT |
Evolution of the average Target Price on Caplin Point Laboratories Limited
Price target over the last 5 years
History of analyst recommendation changes
707fa47.ZkhKc6wqEhpYj9207Hl0rknbkPEBKL-RPlxI_nvc0O4.HjtzQYFeXHI67rfuji4_yni215R4bobiBgwdhgLkv585CgYywmYmTi745Q~4141a83c6cd9fce88067380f7d3fad82
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1,311
INR
Average target price
1,579
INR
Spread / Average Target
+20.47%
High Price Target
1,660
INR
Spread / Highest target
+26.62%
Low Price Target
1,535
INR
Spread / Lowest Target
+17.09%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
C
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CAPLIPOINT Stock
- Consensus Caplin Point Laboratories Limited